FRG appoints Backstrom to CMO

TriMed Staff | | Health Imaging | Artificial Intelligence

Foundation Radiology Group (FRG), a radiology provider which uses board-certified radiologists to interpret diagnostic images for hospitals, has appointed James W. Backstrom, MD, to the position of chief medical officer (CMO).

The Pittsburgh-based FRG said that Backstrom is currently the president of the Pittsburgh Roentgen Society (PRS) and was previously a member of Lucien Diagnostic Imaging, as well as a member of Lucien’s board of directors from 2003 to 2006.

“Backstrom will be instrumental in our mission to build the preeminent national diagnostic imaging and radiology service bureau,” said Brandon W. Chan, CEO of FRG. 

TriMed Staff

Related Content

Mayo Clinic and Microsoft partner to advance generative AI in radiology
ACR partners to create AI foundational model assessment website
Could synthetic images replace the need for contrast?
Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.